Evaluation of a method for improving the detection of hepatocellular carcinoma (Q44833387)

6 December 2017

title

Evaluation of a method for improving the detection of hepatocellular carcinoma (English)

1 reference

6 December 2017

2

1 reference

6 December 2017

8

Ernst J Rummeny

1 reference

6 December 2017

4

Alexander A Fingerle

1 reference

6 December 2017

Edgar Bendik

1

1 reference

6 December 2017

Daniela Münzel

3

1 reference

6 December 2017

Martin Henninger

5

1 reference

6 December 2017

Christian Markus

6

1 reference

6 December 2017

Alain Vlassenbroek

7

1 reference

6 December 2017

Martin Dobritz

9

1 reference

6 December 2017

language of work or name

English

0 references

publication date

3 September 2013

1 reference

6 December 2017

1 reference

6 December 2017

volume

24

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

250-255

1 reference

https://scigraph.springernature.com/pub.10.1007/s00330-013-3006-8

6 December 2017

exact match

0 references

cites work

Diagnostic imaging of hepatocellular carcinoma: recent progress

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Cancer burden in the year 2000. The global picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Three-dimensional CT angiography of the hepatic artery: use of multi-detector row helical CT and a contrast agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Hospital-acquired renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

The optimal contrast media policy in CT of the liver. Part II: Clinical protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

A method for improving iodine contrast enhancement in abdominal computed tomography: experimental study in a pig model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-3006-8

Contrast-induced nephropathy

21 January 2018

1 reference

12 December 2020

Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients

1 reference

12 December 2020

Effects of injection rates of contrast material on arterial phase hepatic CT

1 reference

12 December 2020

Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate--pharmacokinetic analysis and experimental porcine model

1 reference

12 December 2020

Pathophysiology of contrast-induced nephropathy

1 reference

12 December 2020

CT and MR imaging of hepatocellular carcinoma

1 reference

12 December 2020

Role of MDCT in the Diagnosis of Hepatocellular Carcinoma in Patients with Cirrhosis Undergoing Orthotopic Liver Transplantation

1 reference

12 December 2020

Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation

1 reference

12 December 2020

10.1007/S00330-013-3006-8

Identifiers

DOI

1 reference

6 December 2017

1 reference